CN100487125C - 含有VEGFR的截断型可溶性cDNA的重组腺相关病毒及含有上述成分的基因治疗剂 - Google Patents
含有VEGFR的截断型可溶性cDNA的重组腺相关病毒及含有上述成分的基因治疗剂 Download PDFInfo
- Publication number
- CN100487125C CN100487125C CNB2006100000717A CN200610000071A CN100487125C CN 100487125 C CN100487125 C CN 100487125C CN B2006100000717 A CNB2006100000717 A CN B2006100000717A CN 200610000071 A CN200610000071 A CN 200610000071A CN 100487125 C CN100487125 C CN 100487125C
- Authority
- CN
- China
- Prior art keywords
- raav
- carrier
- cdna
- vegfr
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
T84 | MKN74 | MKN45 | NUGC3 | LCSC#1 | |
negative | 20.32±0.28 | 2.95±0.37 | 19.13±0.67 | 16.13±0.95 | 4.78±0.18 |
GFP | 26.62±0.71 | 3.69±0.31 | 11.92±0.72 | 13.55±0.55 | 5.27±0.24 |
AShVEGF-A | 11.62±1.74 | 2.65±0.10 | 12.5±0.37 | 12.91±0.09 | 2.92±0.36 |
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050067661A KR100563099B1 (ko) | 2005-07-26 | 2005-07-26 | VEGFR 트렁케이티드 솔루블 cDNA를 함유하는재조합 아데노-연관 바이러스(rAAV)및 이를 함유하는대장암, 방광암 및/또는 폐암 특이적 유전자 치료제 |
KR1020050067661 | 2005-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1904056A CN1904056A (zh) | 2007-01-31 |
CN100487125C true CN100487125C (zh) | 2009-05-13 |
Family
ID=37179891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100000717A Expired - Fee Related CN100487125C (zh) | 2005-07-26 | 2006-01-06 | 含有VEGFR的截断型可溶性cDNA的重组腺相关病毒及含有上述成分的基因治疗剂 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100563099B1 (zh) |
CN (1) | CN100487125C (zh) |
WO (1) | WO2007013719A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100737286B1 (ko) | 2005-08-31 | 2007-07-13 | 박기랑 | VEGFR 트렁케이티드 cDNA를 함유하는 재조합아데노-연관 바이러스 및 이를 함유하는 암-특이적 유전자치료제 |
CN101591669B (zh) * | 2009-05-15 | 2011-07-27 | 西安交通大学 | 一种野生型egfr高表达的重组hek293细胞 |
KR101248912B1 (ko) * | 2009-12-31 | 2013-03-29 | 한양대학교 산학협력단 | 항혈관신생 활성을 가지는 재조합 아데노바이러스 |
-
2005
- 2005-07-26 KR KR1020050067661A patent/KR100563099B1/ko active IP Right Grant
- 2005-12-20 WO PCT/KR2005/004384 patent/WO2007013719A1/en active Application Filing
-
2006
- 2006-01-06 CN CNB2006100000717A patent/CN100487125C/zh not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
BMP -4 inhibits neural differentiation of murine embryonic stem cells.. Finley MF, et al.Journal of neurobiology,Vol.40 No.3. 1999 |
BMP -4 inhibits neural differentiation of murine embryonic stem cells.. Finley MF, et al.Journal of neurobiology,Vol.40 No.3. 1999 * |
重组腺相关病毒载体介导人血管内皮生长因子165 基因对缺血心肌血管新生的影响. 黄志军等.中国动脉硬化杂志,第12卷第6期. 2004 |
重组腺相关病毒载体介导人血管内皮生长因子165 基因对缺血心肌血管新生的影响. 黄志军等.中国动脉硬化杂志,第12卷第6期. 2004 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007013719A1 (en) | 2007-02-01 |
KR100563099B1 (ko) | 2006-03-27 |
CN1904056A (zh) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2975447C (en) | Spinal subpial gene delivery system | |
ES2745470T3 (es) | Partícula de AAV2 que comprende una proteína de la cápside de AAV2 y un vector que comprende un ácido nucleico que codifica una tripeptidilo peptidasa 1 (TPP1) para el tratamiento de lipofuscinosis ceroide infantil tardía (LINCL) en un mamífero no roedor mediante inyección intraventricular o administración icv | |
JP2020505936A (ja) | 血管系を通過する遺伝子移入の方法および組成物 | |
JP2018506530A5 (zh) | ||
KR101300540B1 (ko) | 인간 글루코키나제 돌연변이체 코딩 유전자, 이에 의하여 코딩된 효소, 재조합 벡터 및 숙주, 이의 약학적 조성물 및 용도, 및 질병의 예방 및 치료 방법 | |
JP2002516295A (ja) | Aavベクターの対流増加送達 | |
KR20080036015A (ko) | 글루코오스 유도성 인슐린 발현 및 당뇨병 치료 방법 | |
US10688285B2 (en) | Spinal subpial gene delivery system | |
US7655467B2 (en) | Compositions and methods for systemic nucleic acid sequence delivery | |
US7771993B2 (en) | Microutrophin and uses thereof | |
JP4660486B2 (ja) | ヒトアポリポ蛋白質(a)クリングルLK68またはLK8遺伝子を有効成分として含有する抗癌治療剤及びそれを使用した癌治療方法 | |
CN100487125C (zh) | 含有VEGFR的截断型可溶性cDNA的重组腺相关病毒及含有上述成分的基因治疗剂 | |
WO2011112902A2 (en) | Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (viper) | |
US20170065685A1 (en) | Serca2 therapeutic compositions and methods of use | |
Chamberlain et al. | A calsequestrin cis-regulatory motif coupled to a cardiac troponin T promoter improves cardiac adeno-associated virus serotype 9 transduction specificity | |
US11434501B2 (en) | Sprr1A as a genetic target for treating neurodegenerative diseases | |
KR102169798B1 (ko) | 아데노바이러스의 감염 및 복제가 가능한 중간엽 줄기세포주 | |
JP2023507741A (ja) | ハンチントン病を処置するための方法 | |
US20020025307A1 (en) | Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues | |
KR100732248B1 (ko) | VEGF 안티센스 cDNA를 함유하는 재조합아데노-연관 바이러스(rAAV)및 이를 함유하는 대장암및/또는 폐암 특이적 유전자 치료제 | |
KR100772424B1 (ko) | ⅤEGF-A,ⅤEGF-B,및 ⅤEGF-C의 안티센스 cDNA를 함유하는 재조합 아데노-연관 바이러스 및 ⅤEGFR 트렁케이티드 솔루블 cDNA를 함유하는 재조합 아데노-연관 바이러스를 포함하는 암의 유전자 치료제 | |
US20230072954A1 (en) | Compositions and methods for circular rna expression | |
KR100697321B1 (ko) | VEGF-A, VEGF-B 및 VEGF-C의 안티센스cDNA를 함유하는 재조합 아데노-연관바이러스(rAAV) 및 이를 함유하는 대장암, 방광암및/또는 폐암 특이적 유전자 치료제 | |
KR100737286B1 (ko) | VEGFR 트렁케이티드 cDNA를 함유하는 재조합아데노-연관 바이러스 및 이를 함유하는 암-특이적 유전자치료제 | |
KR20060005163A (ko) | VEGF-A 안티센스 cDNA와 아데노-연관 바이러스를함유하는 대장암 및/또는 폐암-특이적 유전자 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SCT CO., LTD. Free format text: FORMER OWNER: CHUNGCHEONGBUK-DO Effective date: 20100414 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100414 Address after: North Chungcheong Province Patentee after: SCT Corporation Address before: Dong Shangdang area culture Cheongju Chungbuk Korea 89 Patentee before: Chung Choung Buk Do |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090513 Termination date: 20160106 |